TY - JOUR
T1 - Long‐term follow‐up testing of red cell alloantibodies
AU - Ramsey, Glenn Eugene
PY - 1994/1/1
Y1 - 1994/1/1
N2 - Background: In previous studies, 29 to 34 percent of potentially hemolytic red cell antibodies were not detected after short‐term follow‐ up. Study Design and Methods: To examine long‐term detection, records were reviewed for 44 consecutive patients who were tested more than 5 years after their potentially hemolytic red cell antibodies were first identified in this hospital. Results: After 5 to 10 years, 14 (39%) of 36 Rh, Kell, and Duffy system antibodies were not detected on at least one occasion. Twenty‐two other such antibodies were sought again after more than 10 years; 10 (45%) were not detected. When restimulation by pregnancy was excluded, these rates were 42 and 48 percent, respectively. Conclusion: Clinically significant red cell antibody formation is probably more common than previously realized, because nearly half of these antibodies are undetected after long‐term follow‐ up. 1994 AABB
AB - Background: In previous studies, 29 to 34 percent of potentially hemolytic red cell antibodies were not detected after short‐term follow‐ up. Study Design and Methods: To examine long‐term detection, records were reviewed for 44 consecutive patients who were tested more than 5 years after their potentially hemolytic red cell antibodies were first identified in this hospital. Results: After 5 to 10 years, 14 (39%) of 36 Rh, Kell, and Duffy system antibodies were not detected on at least one occasion. Twenty‐two other such antibodies were sought again after more than 10 years; 10 (45%) were not detected. When restimulation by pregnancy was excluded, these rates were 42 and 48 percent, respectively. Conclusion: Clinically significant red cell antibody formation is probably more common than previously realized, because nearly half of these antibodies are undetected after long‐term follow‐ up. 1994 AABB
UR - http://www.scopus.com/inward/record.url?scp=0028140486&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028140486&partnerID=8YFLogxK
U2 - 10.1046/j.1537-2995.1994.34294143938.x
DO - 10.1046/j.1537-2995.1994.34294143938.x
M3 - Article
C2 - 8310481
AN - SCOPUS:0028140486
SN - 0041-1132
VL - 34
SP - 122
EP - 124
JO - Transfusion
JF - Transfusion
IS - 2
ER -